Skip to main content

Table 1 Information of patients and corresponding patient-derived xenograft mouse models

From: Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies

#

Model

Gender

Smoking status

EGFR/Kras mutation

Age

Pathology

Stage

TNM stage

Engrafted model

1

L004

M

Y

WT

61

AC

IIIA

T2N2M0

Yes

2

L023

M

Y

Kras:G12S

55

SCC

IIA

T3N2M0

Yes

3

L030

M

Y

Q61H

64

SCC

IV

T2N0M1

Yes

4

L101

M

Y

WT

63

AC

IA

T1N0M0

No

5

L102

F

N

WT

53

AC

IA

T1N0M0

No

6

L103

M

N

n/a

45

SCC

IIA

T3N0M0

No

7

L104

M

N

WT

71

SCC

IIB

T2N1M0

Yes

8

L105

M

N

WT

76

AC

IB

T2N0M0

No

9

L106

F

N

Exon19Del

67

AC

IIB

T2N1M0

No

10

L107

M

Y

WT

76

SCC

IB

T2N0M0

No

11

L108

F

N

L858R

71

AC

IIB

T2N1M0

No

12

L110

M

Y

WT

66

SCC

IB

T2N0M0

Yes

13

L111

M

N

L858R

72

AC

IA

T1N0M0

No

14

L113

M

Y

WT

73

SCC

IB

CT2N0M0

No

15

L115

M

n/a

Exon19Del

55

AC/SCC

IIIA

T2N2M0

Yes

16

L116

M

N

WT

57

SCC

IIIA

ST2N2M0

No

17

L117

M

N

WT

66

AC

IIB

ST2N1M0

No

18

L118

M

Y

L858R

31

AC

IV

T1N0M1

No

19

L119

M

Y

WT

48

AC

IA

ST1N0M0

No

20

L121

M

Y

WT

69

SCC

IV

T2N0M1

Yes

21

L123

M

Y

WT

50

SCC

IB

T2N0M0

Yes

22

L124

F

N

L858R

50

AC

IIIA

T2N2Mx

No

23

L125

F

N

WT

47

AC

IIIA

T2N2M0

No

24

L126

M

N

WT

59

AC

IB

T2N0M0

No

25

L127

F

N

L858R

66

AC

IB

T2N0M0

No

26

L128

M

Y

WT

61

SCC

IIIA

T2N2M0

No

27

L130

M

N

n/a

66

SCC

IB

T2N0M0

No

28

L131

F

N

Kras:G12V

60

AC

IV

N0M1

No

29

L132

M

Y

WT

69

AC

IIIA

ST3N1M0

No

30

L133

M

N

WT

61

SCC

IIB

T2N1M0

Yes

31

L140

M

Y

WT

58

SCC

IIIA

T2N2M0

Yes